The health care reform debate rages on as the Supreme Court continues to deliberate on whether or not the Affordable Care Act (ACA) is constitutionally sound.
The health care reform debate rages on as the Supreme Court continues to deliberate on whether or not the Affordable Care Act (ACA) is constitutionally sound.
The ramifications of whatever outcome is eventually reached are far-reaching, says Daniel Shuchman of Forbes. In his recent OP/ED piece “A Right to Health Care, But No Right to Pay For It?” Shuchman goes on to say that “the implications are potentially more troubling for the future of economic liberty than the individual mandate itself,” and even presents a hypothetical patient/doctor conversation that could become the norm if the proposed reform takes place.
The Wall Street Journal’s John Cochrane believes that, regardless of the outcome of the Supreme Court decision on Obamacare, we will all still be left with a broken healthcare system. Why? Because, according to Cochrane, the ACA fails to address the root causes of the current broken system, such as skewed physician incentives, inconsistent pricing, and the simple fact that health insurance is not restricted to catastrophic coverage.
Washington Post writer Olga Khazan reminds us of another aspect of the Supreme Court deliberations. Remember those health insurance exchanges — the “marketplaces” for health plans that were established by the ACA? Well, many government contractors are beginning to wonder whether their efforts will yield anything at all. With so much hinging on the decision of the Supreme Court, it looks like “many of the health care exchanges will stop.”
But despite the arguments for and against Obamacare (and in addition to those who would like to defend the status quo), the simple fact is that there are only nine opinions that matter. Chief Justice John Roberts and Justice Samuel Alito represent two of those opinions. Here are some of their concerns with the ACA as it stands now:
Chief Justice John Roberts: “If I understand the law, the policies that you’re requiring people to purchase ... must contain provision for maternity and newborn care, pediatric services and substance use treatment. It seems to me that you cannot say that everybody is going to need ... substance use treatment or pediatric services, and yet that is part of what you require them to purchase.”
Justice Samuel Alito: “The mandate is forcing these people (young, healthy individuals) to provide a huge subsidy to the insurance companies for other purposes that the act wishes to serve ... isn’t it the case that what this mandate is really doing is not requiring the people who are subject to it to pay for the services that they are going to consume? It is requiring them to subsidize services that will be received by somebody else.”
What are your opinions on the Affordable Care Act?
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More